PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% recall: Contamination
PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL…
Why was PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% recalled?
GMP Deviations: potential glass contamination
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: FB9014A Exp. 12/09/2019; FB9017A Exp. 12/16/2019
- Product
- PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL…
- Recalling firm
- Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
- Quantity
- 1370 bags
- Distribution
- Nationwide.
- Recall date
- October 30, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)